Evidence map›Paper›PMID 37542548›Full record

ArticleJournal of cancer research and clinical oncology2023

Development and external validation of a clinical-radiomics nomogram for preoperative prediction of LVSI status in patients with endometrial carcinoma.

Jingya Chen, Xiaorong Wang, Haoyi Lv, Wei Zhang, Ying Tian, Lina Song, Zhongqiu Wang

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jingya Chen *Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210009, Jiangsu, China.
Xiaorong WangTaixing People's Hospital, Taizhou, China.
Haoyi LvUniversity of Science and Technology of China, Hefei, Anhui, China.
Wei ZhangAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing, Jiangsu Province, China.
Ying TianAffiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210009, Jiangsu, China.
Lina SongAffiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210009, Jiangsu, China.
Zhongqiu Wang *Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210009, Jiangsu, China. zhq2001us@163.com.
Nanjing University of Chinese Medicine · CNJiangsu Province Hospital · CNTaixing People's Hospital · CNUniversity of Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo develop and validate a model that incorporates radiomics based on MRI scans and clinical characteristics to predict lymphovascular invasion (LVSI) in endometrial cancer (EC) patients.

methodsThere were 332 patients with EC enrolled retrospectively in this multicenter study. Radiomics score (Radscore) were computed using the valuable radiomics features. The independent predictors of LVSI were identified by univariate logistic analysis. Multivariate logistic regression was used to develop a clinical-radiomics predictive model. Based on the model, a nomogram was developed and validated internally and externally. The nomogram was evaluated with discrimination, calibration, decision curve analysis (DCA), and clinical impact curves (CIC).

resultsThree predictive models were constructed based on clinicopathological features, radiomic factors and a combination of them, and that the clinic-radiomic model performed best among the three models. Four independent factors comprised the clinical-radiomics model: dynamic contrast enhancement rate of late arterial phase (DCE2), deep myometrium invasion (DMI), lymph node metastasis (LNM), and Radscore. Clinical-radiomics model performance was 0.901 (95% CI 0.84-0.96) in the training cohort, 0.80 (95% CI 0.68-0.92) in the internal validation cohort, and 0.81 (95% CI 0.73-0.9) in the external validation cohort for identifying patients with LVSI, respectively. The model is used to develop a nomogram for clinical use.

conclusionsThe MRI-based radiomics nomogram could serve as a noninvasive tool to predict LVSI in EC patients.

Indexed as

Endometrial cancerLymphovascular invasionMRINomogramRadiomics

Identifiers

PMID37542548
PMCPMC11796764
OpenAlexW4385616433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.